Ran Jin

Also affiliated with AstraZeneca (Brazil)

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer”.

Real-world use of bevacizumab-awwb, a bevacizumab biosimilar, in US patients with metastatic colorectal cancer

Future Oncology(2021)10.2217/fon-2021-0588

N/A

0.416DataRank · unranked

15 citations

Richard W DeClue, Neil A Accortt, Ran Jin, Darcie Sandschafer, Debra Wertz +2 more

Disparities in Risks of Inadequate and Excessive Intake of Micronutrients during Pregnancy

Journal of Nutrition(2021)10.1093/jn/nxab273

N/A

0DataRank · unranked

44 citations

Robyn Harte, Brandy M. Ringham, Patricia M. Guenther, Regan L Bailey, Akram N. Alshawabkeh +37 more